Clinigence Holdings (NUTX) Live Share Price, Invest From India

Clinigence Holdings Stock Performance

as on November 12, 2026 at 3:43 am IST

Day's Low
Day's High
$187.00
Day's Price Range
$196.69
$194.66
3.94%
Downside
1.04%
Upside
52 Week's Low
52 Week's High
$83.99
52-Week Price Range
$226.16
$194.66
56.85%
Downside
16.18%
Upside

Clinigence Holdings share price movements today

Previous Close: $186.25
Open: $189.50
Volume: 209.9K
Market Cap: $1.2B
Day's Low - High: $187.00 - $196.69
52 Week Low - High: $83.99 - $226.16

Clinigence Holdings Historical Returns

1 Month Return: -9.71 %
3 Month Return: + 11.9 %
1 Year Return: + 66.34 %
3 Year Return: + 417.36 %
5 Year Return: 0 %

Clinigence Holdings Stock Fundamentals & Key Indicators

Check Clinigence Holdings market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$1.2B

EPS (TTM)

23.83

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

7.82

Industry PE ratio

4.27

PEG Ratio

0.36

EBITDA

332.9M

Revenue (TTM)

796.5M

Profit Margin

47.79%

Return On Equity TTM

43.76%

Clinigence Holdings vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Clinigence Holdings with its industry peers.

Company	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin %	Dividend Yield %
Clinigence Holdings	Buy	$1.2B	NA	7.82	47.79%	0.00%
Tenet Healthcare	StrongBuy	$22.5B	265.86%	8.36	29.38%	0.00%
Encompass Health	StrongBuy	$13.5B	122.50%	21.99	38.53%	0.57%
HCA Healthcare	Buy	$103.4B	106.74%	16.66	21.69%	0.62%
DaVita	Buy	$12.0B	68.92%	13.76	30.96%	0.00%

See all

Stock Returns calculator for Clinigence Holdings Stock including INR - Dollar returns

The Clinigence Holdings stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

Clinigence Holdings investment value today

Current value as on today

₹1,84,095

Returns

₹84,095

(+84.1%)

Returns from Clinigence Holdings Stock

₹73,850 (+73.85%)

Dollar Impact

₹10,245 (+10.25%)

Analyst Recommendation on Clinigence Holdings Stock

Based on 2 analysts

BUY

100.00%

Buy

0.00%

Hold

0.00%

Sell

Based on 2 analysts, 100% of analysts recommend a 'BUY' rating for Clinigence Holdings. Average target price of $296.17

Clinigence Holdings Share Price Target

Get share price movements and forecasts by analysts on Clinigence Holdings.

What analysts predicted

34.27%UPSIDE

Target Price

$296.17

Current Price

$194.66

Analyzed by

2 Analysts

High

$357

Target

$296.17

Low

$306

Clinigence Holdings target price $296.17, a slight upside of 34.27% compared to current price of $194.66. According to 2 analysts rating.

Indian Investors' Interest in Clinigence Holdings Stock

Search interest for Clinigence Holdings Stock has decreased by -38% in the last 30 days, reflecting a downward trend in search activity.

Time period: October 12, 2026 to November 11, 2026

Change:-38% versus previous 30 day period

Clinigence Holdings Quarterly Profit & Loss

All numbers in Millions USD

	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Mar 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026	Sep 2026
Total Revenue	69	67	76	78	211	267	151	216	210	217
Gross Profit	13	10	22	21	118	154	46	91	141	101
Operating Income	-26	1	5	9	72	130	30	81	121	77
EBITDA	-21	8	13	7	73	134	36	86	127	83
Interest Expense	4	4	5	5	6	5	4	4	4	4
Depreciation	4	4	4	4	5	5	5	5	5	5
Income Before Tax	-30	0	3	-2	62	123	25	76	117	72
Income Tax Expense	-2	0	0	4	18	27	9	13	20	15
Net Income	-31	0	0	-8	14	55	11	46	65	40
Net Profit Margin	18.97%	15.06%	29.65%	27.82%	55.88%	57.83%	30.42%	42.37%	67.04%	46.65%

Clinigence Holdings Annual Profit & Loss

All numbers in Millions USD

	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Mar 2025	Dec 2025
Total Revenue	0	1	97	274	331	219	247	479	875
Gross Profit	0	0	56	157	179	15	34	196	444
Operating Income	-2	0	34	153	170	-406	-31	130	275
EBITDA	-5	0	38	158	183	-394	-14	148	287
Interest Expense	0	0	3	6	6	12	16	19	22
Depreciation	0	0	2	5	7	13	17	18	20
Income Before Tax	-6	0	32	145	169	-419	-48	109	244
Income Tax Expense	-	-	-	0	0	13	-5	14	64
Net Income	0	-2	20	105	132	-424	-45	52	70
Net Profit Margin	-952.00%	31.82%	100.00%	57.51%	54.08%	7.03%	14.04%	40.89%	50.76%

Clinigence Holdings Quarterly Cash Flow

All numbers in Millions USD

	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Mar 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026	Sep 2026
Net Income	-27	0	3	-7	21	96	11	62	96	57
Operating Cash Flow	-1	3	13	6	50	99	70	75	34	78
Investing Cash Flow	0	0	-1	0	0	0	-5	-1	-2	-5
Financing Cash Flow	-3	5	-1	0	-6	-29	-45	-49	-35	-26
Change in Cash	-4	8	10	6	44	69	19	24	-3	46

Clinigence Holdings Annual Cash Flow

All numbers in Millions USD

	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Mar 2025	Dec 2025
Net Income	32	145	168	-432	-45	95	180
Operating Cash Flow	12	86	173	50	1	23	248
Investing Cash Flow	-31	-61	-36	-4	-11	-2	-5
Financing Cash Flow	21	-7	-125	-48	-2	1	-97
Change in Cash	2	17	10	-1	-12	21	145

Global Institutional Holdings in Clinigence Holdings

Check out the Institutions with significant holdings in Clinigence Holdings.

Funds	Holdings
Thomas T. Vo	30.65%
BlackRock, Inc.	5.94%
Avantis	4.81%
Vanguard	3.57%
iShares	3.10%

See all

Insights on Clinigence Holdings

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

POSITIVE IMPACT
Price Rise
In the last 6 months, NUTX stock has moved up by 40.2%
POSITIVE IMPACT
Revenue Rich
Revenue is up for the last 2 quarters, 210.75M → 217.61M (in $), with an average increase of 3.2% per quarter
POSITIVE IMPACT
Best in 3 Years
In the last 3 years, NUTX has outperformed top 5 stocks with highest market-cap in its industry
POSITIVE IMPACT
Best in 1 Year
In the last 1 year, NUTX has outperformed top 5 stocks with highest market-cap in its industry
NEGATIVE IMPACT
Profit Down
Netprofit is down for the last 2 quarters, 65.84M → 40.22M (in $), with an average decrease of 38.9% per quarter

About Clinigence Holdings

Nutex Health, Inc. functions as a technology-powered enterprise delivering healthcare services, structured into two key segments: its Hospital division and its Population Health Management division. The Hospital division is tasked with developing and overseeing various healthcare models, encompassing micro-hospitals, specialized medical centers, and hospital outpatient facilities. This segment currently owns and operates 21 locations spanning eight different states. Meanwhile, the Population Health Management division establishes and manages provider networks, such as independent physician associations. Additionally, its management services organizations furnish administrative, operational, and support assistance to its associated hospitals and physician groups. A proprietary, cloud-based technology platform within this division is crucial; it aggregates patient and provider data from multiple information systems, settings, and sources to construct a holistic view, thereby enabling more effective care delivery. The company maintains its corporate headquarters in Houston, Texas.

Organisation	Clinigence Holdings
Headquarters	1776 Yorktown Street, Houston, TX, 77056, US
Industry	Medical - Care Facilities
CEO	Thomas T. Vo

Key Management of Clinigence Holdings

Name	Title
Dr. Michael Chang M.D.	Chief Medical Officer
Ms. Jennifer Rodriguez	Investor & Public Relations Manager
Dr. Thomas T. Vo M.B.A., M.D.	Chairman of the Board & CEO
Dr. Warren Hosseinion M.D.	President & Director
Mr. Wesley Bamburg FACHE	Chief Operating Officer
Ms. Sarah Wallace	Director of Human Resources
Ms. Elisa Michael Luqman Esq., J.D., M.B.A.	Chief Legal Officer & Board Secretary of SEC
Mr. Jon C. Bates CPA, M.B.A.	Chief Financial Officer
Ms. LaTanya Brackens	Director of Compliance
Ms. Vivian Sanders M.B.A.	Director of Marketing

FAQs

What is Clinigence Holdings share price today?

Clinigence Holdings share price today is $194.66 as on November 11, 2026 at 10:13 pm IST. Clinigence Holdings share today touched a day high of $196.69 and a low of $187.00.

What is the 52 week high and 52 week low for Clinigence Holdings share?

Clinigence Holdings share touched a 52 week high of $226.16 on October 6, 2026 and a 52 week low of $83.99 on March 6, 2026. Clinigence Holdings stock price today i.e. November 11, 2026 at 10:13 pm IST is trending at $194.66,which is 13.93% down from its 52 week high and 131.77% up from its 52 week low.

What is Clinigence Holdings's market capitalisation today?

Clinigence Holdings market capitalisation is $0.00T as on November 11, 2026 at 10:13 pm IST.

How to invest in Clinigence Holdings Stock (NUTX) from India?

Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
Step 2: Search for Clinigence Holdings on INDmoney app. Click on Buy button.

What is the minimum amount required to buy Clinigence Holdings Stock (NUTX) from India?

Indian investors can start investing in Clinigence Holdings (NUTX) shares with as little as ₹93.68000030517578 or $1 (as of November 11, 2026 at 10:14 pm IST) using the INDmoney app.
For example: If you want to invest $10 or ₹936.80 in Clinigence Holdings stock (as per the Rupee-Dollar exchange rate as on November 11, 2026 at 10:14 pm IST). Based on Clinigence Holdings share’s latest price of $194.66 as on November 11, 2026 at 10:13 pm IST, you will get 0.0514 shares of Clinigence Holdings. Learn more about fractional shares .